| abstract |
PROBLEM TO BE SOLVED: To provide a truncated HCV envelope protein useful for immunoassay and therapeutic / prophylactic vaccine. A glycoprotein expressed from the E1 region of HCV, comprising a deletion in a part of the sequence found in the region spanning amino acids 330 to 380 (number from the beginning of the HCV polyprotein) of the E1 region , Glycoproteins, and glycoproteins expressed from the E2 region of HCV, with deletions in part of the sequence found in the region spanning amino acids 660-830 (number from the beginning of the HCV polyprotein) of the E2 region HCV truncated glycoprotein selected from the group consisting of glycoproteins. [Selection figure] None |